|
| 毕得医药(688073)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-10-11 | 90.88 | 1.00% | 4323.42 | 4764.88 | 4255.55 | 46.82% | 首发战略配售股份 | | 2024-03-25 | 516.22 | 5.68% | 4255.55 | 4832.74 | 3739.33 | 41.14% | 首发原股东限售股份 | | 2023-10-11 | 1762.33 | 19.39% | 3716.31 | 5371.98 | 1980.00 | 21.79% | 首发原股东限售股份,首发战略配售股份 | | 2023-04-11 | 60.82 | 0.94% | 1395.70 | 5095.94 | 1334.88 | 20.56% | 首发机构配售股份 | | 2022-10-11 | 1334.88 | 20.56% | 1334.88 | 5156.76 | 1334.88 | 20.56% | 首发一般股份 |
|